NDC 80425-0397-01 - Pregabalin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
80425-0397
Requested NDC
80425-0397-01
Package NDCs from labels
80425-0397-3, 80425-0397-2, 80425-0397-1, 80425-0397-01
Manufacturer
Advanced Rx of Tennessee, LLC
Effective date
2024-06-05
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Pregabalin - Advanced Rx of Tennessee, LLCAdvanced Rx of Tennessee, LLC2024-06-05HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
80425-0397-1Pregabalin30 in 1 BOTTLECAPSULE302
80425-0397-2Pregabalin60 in 1 BOTTLECAPSULE602
80425-0397-3Pregabalin90 in 1 BOTTLECAPSULE902

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
80425-0397PREGABALIN CAPSULE [ADVANCED RX OF TENNESSEE, LLC]2Current NDC, 3 package rows20240606_1a15cd11-0db9-2bc8-e063-6394a90a11fb.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
80425-0397-1EA - Each80425-03973c72220d-e85e-4787-a30e-d5eb63357c0612024-07-12
80425-0397-2EA - Each80425-03973fcf1d01-f037-44e6-aa3b-68cb8058e64412024-07-12
80425-0397-3EA - Each80425-0397952f1e6a-ae82-4b78-a129-af4fcc77997912024-07-12

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 68 of 121 · 2,408 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PregabalinPREGABALINPreferred Pharmaceuticals, Inc.25345672-1368-4e3a-95b2-ca45fe1202942025-09-12Warnings, Adverse reactionsExact identifier
application number: ANDA208677
rxcui: 483440
unii: 55JG375S6M
PregabalinPREGABALINAphena Pharma Solutions - Tennessee, LLC3e9cfeb9-1e2b-ea79-e063-6394a90a67b12025-09-12Warnings, Adverse reactionsExact identifier
application number: ANDA208677
rxcui: 577127
unii: 55JG375S6M
Dry eye reliefPOLYETHYLENE GLYCOL AND PROPYLENE GLYCOLCARDINAL HEALTH 110, LLC. DBA LEADERf8da3af5-9172-4023-be82-0fd5bd8916162025-09-12WarningsExact identifier
unii: 6DC9Q167V3
PregabalinPREGABALINPreferred Pharmaceuticals Inc.e8e272a4-c181-4573-822b-2bb315b6ad372025-09-12Warnings, Adverse reactionsExact identifier
rxcui: 483438
unii: 55JG375S6M
PREGABALINPREGABALINCadila Pharmaceuticals Limited170c0c95-2ee8-4dff-bbd6-b87a21e8cf812025-09-12Warnings, Adverse reactionsExact identifier
rxcui: 483440
rxcui: 483444
rxcui: 483442
rxcui: 577127
rxcui: 483448
rxcui: 483438
rxcui: 483450
rxcui: 483446
unii: 55JG375S6M
PregabalinPREGABALINPreferred Pharmaceuticals, Inc.ceedde96-fdaf-4708-9ca1-e48e052cde752025-09-12Warnings, Adverse reactionsExact identifier
application number: ANDA208677
rxcui: 483438
unii: 55JG375S6M
PregabalinPREGABALINPreferred Pharmaceuticals Inc.a0da0534-b386-4c93-ae89-03b0e3325e022025-09-11Warnings, Adverse reactionsExact identifier
rxcui: 483450
unii: 55JG375S6M
PregabalinPREGABALINPreferred Pharmaceuticals, Inc.1760ccdc-46f7-4182-a563-96b13212cb7e2025-09-11Warnings, Adverse reactionsExact identifier
application number: ANDA208677
rxcui: 483450
unii: 55JG375S6M
sunscreenTITANIUM DIOXIDE(NANO)Mingyu (guangdong) Cosmetics Technology Co., Ltd3e6fe9f3-486b-bba7-e063-6294a90adf372025-09-10WarningsExact identifier
unii: 15FIX9V2JP
PregabalinPREGABALINPreferred Pharmaceuticals, Inc.3dbfd868-8408-4514-ba1c-04a5d095c16a2025-09-10Warnings, Adverse reactionsExact identifier
application number: ANDA208677
rxcui: 483448
unii: 55JG375S6M
PregabalinPREGABALINAphena Pharma Solutions - Tennessee, LLC31e7caf6-0a8b-f343-e063-6294a90ad7292025-09-08Warnings, Adverse reactionsExact identifier
application number: ANDA208677
rxcui: 483438
unii: 55JG375S6M
PHOFAY Matte Sunscreen Liquid Foundation SPF 30 5ENSULIZOLE ,HOMOSALATE ,OCTINOXATE,TITANIUM DIOXIDEHangzhou Jingshen Trading Co., Ltd.3dbb07e2-971c-284d-e063-6294a90a437f2025-09-06WarningsExact identifier
unii: 15FIX9V2JP
PHOFAY Matte Sunscreen Liquid Foundation SPF 30 6ENSULIZOLE,HOMOSALATE ,OCTINOXATE ,TITANIUM DIOXIDEHangzhou Jingshen Trading Co., Ltd.3e069cb2-c4c5-abf5-e063-6394a90a56b02025-09-06WarningsExact identifier
unii: 15FIX9V2JP
PowderTITANIUM DIOXIDEOxygen Development LLC08b52f29-c1a0-c673-e063-6294a90a9a7a2025-09-05WarningsExact identifier
unii: 15FIX9V2JP
PowderTITANIUM DIOXIDEOxygen Development LLC08b8003f-40be-3380-e063-6294a90a4f6b2025-09-05WarningsExact identifier
unii: 15FIX9V2JP
PREGABALINPREGABALINRising Pharma Holdings, Inc.dbebfa61-0685-41b4-8364-00b8d8b737142025-09-05Warnings, Adverse reactionsExact identifier
rxcui: 483440
rxcui: 483444
rxcui: 483442
rxcui: 577127
rxcui: 483448
rxcui: 483438
rxcui: 483450
rxcui: 483446
unii: 55JG375S6M
PHOFAY Matte Sunscreen Liquid Foundation SPF 30, 1ENSULIZOLE, HOMOSALATE, OCTINOXATE, TITANIUM DIOXIDEHangzhou Jingshen Trading Co., Ltd.18130858-429c-4ed4-a75b-5bc0144812502025-09-04WarningsExact identifier
unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 38C DeepOCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDEDolce & Gabbana Beauty S.R.L0358a87d-8002-4f3e-851a-3a582d356edf2025-09-03WarningsExact identifier
unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 39N DeepOCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDEDolce & Gabbana Beauty S.R.L34dfc4c5-44f7-4531-97ba-8846ebe147242025-09-03WarningsExact identifier
unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 40C DeepOCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDEDolce & Gabbana Beauty S.R.Lcf4b6f45-d4ae-4665-87b4-c5af4910befa2025-09-03WarningsExact identifier
unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.